Results 211 to 220 of about 291,899 (358)

Post-acute withdrawal syndrome (PAWS) after stopping antidepressants: a systematic review with meta-narrative synthesis. [PDF]

Epidemiol Psychiatr Sci
Rennwald A, Hengartner MP.
europepmc   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

Epilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang, Emilio Perucca, Samuel F. Berkovic, Piero Perucca   +3 more
wiley   +1 more source

Optimal Drug, Optimal Dose, or Both in the Pharmacological Treatment of Neonatal Opioid Withdrawal Syndrome? [PDF]

Clin Pharmacol Ther
Kraft WK.
europepmc   +1 more source

The Role of a Medical Toxicologist for Assistance in the Treatment of Alcohol Withdrawal Syndrome [PDF]

, 2012

openalex   +1 more source

Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure

European Journal of Heart Failure, EarlyView.
Tibor Kempf, Welf Geller, Jan Fuge, Mircea‐Andrei Sandu, Marius M. Hoeper, Roman Pfister, Sascha Macherey‐Meyer, Stefan Störk, Daniel Scheiber, Jürgen Bogoviku, Jörn Tongers, Tarek Bekfani, Christoph Schindler, Dominik Berliner, Udo Bavendiek, Johann Bauersachs   +15 more
wiley   +1 more source

A model‐based cost‐effectiveness estimates of hormonal therapy in Indian children with infantile epileptic spasms syndrome

Epilepsia Open, EarlyView.
Abstract Objective Due to the conflicting evidence and expected regional therapeutic variations for cost‐effectiveness in children with infantile epileptic spasms syndrome (IESS), this study assessed treatment effectiveness, safety, Health‐Related Quality of Life (HRQoL), and performed a cost‐effectiveness analysis (CEA) for hormonal therapies in ...
Nagita Devi, Priyanka Madaan, Saroj Kundan Bharti, Jitendra Kumar Sahu, Dipika Bansal   +4 more
wiley   +1 more source

Bayesian Population Pharmacokinetic Modeling of Ondansetron for Neonatal Opioid Withdrawal Syndrome. [PDF]

Clin Transl Sci
Lam K, Mondick JT, Peltz G, Wu M, Kraft WK.   +4 more
europepmc   +1 more source

Sustained disease-free survival achieved with withdrawal of immunosuppression after rapid relapse of myelodysplastic syndrome following myeloablative allogeneic hematopoietic transplantation: a case report [PDF]

, 2013
Betty K. Hamilton, Gregory Vereb, Edward A. Copelan   +2 more
openalex   +1 more source

Enhanced response inhibition in patients with drug‐resistant juvenile myoclonic epilepsy: Event‐related potentials evidence of excitatory–inhibitory imbalance

Epilepsia Open, EarlyView.
Abstract Objective To investigate the excitatory–inhibitory imbalance in drug‐resistant Juvenile Myoclonic Epilepsy (DR‐JME) patients using event‐related potentials during motor and cognitive tasks. Methods Eighteen JME patients and 11 healthy controls performed a visual Go No‐Go task while sitting (single‐task) and walking (dual‐task).
Leviashvilli Sarah, Mor Yam, Lilach Goldstein, Firas Fahoum, Ben‐Eliezer Noam, Inbal Maidan   +5 more
wiley   +1 more source

Valproate-Enhanced Protocols for Alcohol Withdrawal Syndrome: A Brief Review and Retrospective Study of Efficacy and the Ability to Reduce Benzodiazepine Use. [PDF]

Pharmaceuticals (Basel)
Pardossi S, Cuomo A, Gualtieri G, Pinzi M, Piumini G, Fagiolini A.   +5 more
europepmc   +1 more source